Izvestia: The Patients' Union Asked The Authorities To Solve The Problem With The Shortage Of Medicines In Russia

Izvestia: The Patients' Union Asked The Authorities To Solve The Problem With The Shortage Of Medicines In Russia
Izvestia: The Patients' Union Asked The Authorities To Solve The Problem With The Shortage Of Medicines In Russia

Video: Izvestia: The Patients' Union Asked The Authorities To Solve The Problem With The Shortage Of Medicines In Russia

Отличия серверных жестких дисков от десктопных
Video: Soviet and Post-Soviet Histories of Race 2023, February
Anonim

MOSCOW, December 21. / TASS /. The All-Russian Union of Patients (VSP), on behalf of 20 patient associations, sent a letter to the President of the Russian Federation, as well as to the Government of the Russian Federation, the Ministry of Health and the Ministry of Industry and Trade with a list of 42 drugs, the shortage of which has been observed in Russia for the past several months, and proposed a number of measures to solve the problem. This was reported on Monday by the Izvestia newspaper with reference to the letter.

“In a number of cases, responses to official inquiries from specialized NGOs were either not received, or contained information that this problem did not exist,” Yury Zhulev, co-chairman of the GSP, told the newspaper. In his opinion, difficulties arose with assessing the actual demand, as well as with the distribution of drugs among patients who need them due to the coronavirus and due to the presence of other diseases. Today, patients with coronavirus infection are treated with the same drugs that patients with cystic fibrosis take, the VSP co-chairman explained.

According to the publication, among the scarce drugs are vital for the treatment of cancer patients, patients with cystic fibrosis, multiple sclerosis, rheumatic diseases, primary immunodeficiency and other diseases. In addition, interruptions have occurred with medications that are used to treat rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic diseases. In addition to hydroxychloroquine, these are azathioprine, mycophenolate mofetil, methotrexate, methylprednisolone and others.

According to VSP experts, since April 2020, there have also been interruptions in drugs for chronic diseases, including antibiotics (levofloxacin and azithromycin), anticoagulants (sodium enoxaparin), a number of antineoplastic and immunosuppressive drugs (hydroxychloroquine and tocilizumab). The GSP added that the problem has worsened since September 2020.

Among the measures that can help eliminate the shortage, the GSP sees an increase in funding for drug provision in outpatient and inpatient conditions, an increase in the production of Russian drugs and substances, a change in the mechanism for regulating the maximum selling prices for drugs from the list of vital and essential drugs for medical use, taking into account increasing world prices and simplifying the registration renewal scheme for medicinal products that have previously passed the registration procedure.

Izvestia sent a request to the government, the Ministry of Health and the Ministry of Industry and Trade with a request to comment on the GSP's appeal.

Popular by topic